Liang Qiao
Prof
Principal Research Fellow
PhD/M.D
liang.qiao@wimr.org.au
Tumor Biology and Liver Cancer Stem Cell Research Group
Currently open to PHD and Honours students in the topic areas of:
Liver cancer
Chronic liver disease
Cancer stem cells
Organoids
Pre-clinical models
Experimental cancer therapy

Biography
Dr. Qiao is a Principal Research Fellow at the Storr Liver Centre and an Adjunct Professor of the Faculty of Medicine and Health, the University of Sydney. He leads a research group in the Storr Liver Centre working on liver cancer and chronic liver diseases (e.g., MAFLD) with a focus on the roles of cancer stem cells in the pathogenesis of liver cancer and therapy development. His group has generated liver biobank containing primary tissues from various liver diseases and biomaterials derived from the tissues (e.g., organoids). Dr. Qiao holds senior editorial roles in multiple international journals (e.g., Specialty Chief Editor for Front Oncol; Associate Editor for Therapeutic Advances in Medical Oncology; Senior Editor for Cancer Letters; Co-Chief Editor for Current Stem Cell Research & Therapy; consulting editor for Pharmacological Research, etc). Dr. Qiao has authored >220 articles in peer-reviewed journals including in Cell, J Hepatol, Hepatology, Gut, Mol Cancer, Cancer Res, Cancer Letts, BBA Rev on Cancer, and Adv Drug Deliv Rev. His h-index is 63. He is listed since 2022 as one of the most highly cited and world’s top 2% scientist in the field of Oncology, Gastroenterology and Hepatology).
Research interests
Liver cancer, chronic liver disease, cancer stem cells, organoids, pre-clinical models, experimental cancer therapy
Adjunct roles
Professor | Faculty of Medicine and Health, the University of Sydney |
Additional information
Google Scholar: https://scholar.google.com.au/citations?hl=en&user=OYEQ_HUAAAAJ&view_op=list_works&sortby=pubdate
Current grants
Sydney Cancer Partners Seed Grant | 2024 | Investigating the role of Jagged2 in MALFD-HCC tumorigenesis and progression using a multi-lineage liver organoid model |
Research and Education Network | 2024 | Understanding the key role of RALYL in liver cancer heterogeneity and drug resistance |
Affiliations
Faculty of Medicine and Health, the University of Sydney
Professional Associations and Organisations
2012- | Faculty Member of the Westmead Institute for Medical Research | Member |
2013- | Australian Society for Stem Cell Research | Organizing Committee Member |
2013- | Cell Reprogramming Australia | Academic Member |
2013- | NSW Stem Cell Network | Member |
2013 | NHMRC Research Translation Faculty | Member |
2023 | Scientific Advisory Committee, Australasian Gastro-Intestinal Trials Group/GI Cancer Institute | Member |
2017 | Sydney West Translational Cancer Research Centre | Member |
2015 | University of Sydney Cancer Research Network | Member |
2013 | European Association for the Study of the Liver | Member |